Microfluidics and coagulation biology

Annual Review of Biomedical Engineering

Volumn 15, Issue , 2013, Pages 283-303

  Colace, Thomas V ^a   Tormoen, Garth W ^b   McCarty, Owen J T ^b   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

collagen; fibrin; hemostasis; platelet function; thrombosis; von Willebrand factor

Indexed keywords

CLINICAL DIAGNOSTICS; CONSTANT PRESSURE DROPS; FIBRIN; HEMOSTASIS; INTRALUMINAL THROMBUS; MICRO-FLUIDIC DEVICES; THROMBOSIS; VON WILLEBRAND FACTOR;

BIOPOLYMERS; COAGULATION; COLLAGEN; DIAGNOSIS; FLUIDIC DEVICES; PLATELETS;

MICROFLUIDICS;

APIXABAN; BIOPOLYMER; CITRIC ACID; EDETIC ACID; FIBRIN; HEPARIN; MATRIX PROTEIN; PHOSPHATIDYLSERINE; THROMBOCYTE RECEPTOR; THROMBOPLASTIN; TRYPSIN INHIBITOR;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BLOOD RHEOLOGY; EX VIVO STUDY; FLOW RATE; GENERAL MEDICAL DEVICE; HEMODYNAMICS; HUMAN; INFUSION PUMP; MICROFLUIDICS; MOLECULAR DYNAMICS; MOLECULAR IMAGING; NONHUMAN; SHEAR RATE; SURFACE PROPERTY; SYSTEMS BIOLOGY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD PLATELETS; CELL ADHESION; HEMODYNAMICS; HEMOSTASIS; HUMANS; MICE; MICROFLUIDICS; MODELS, STATISTICAL; PERMEABILITY; PROTEOMICS; RHEOLOGY; SYSTEMS BIOLOGY; THROMBOPLASTIN; THROMBOSIS;

EID: 84880515343     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071812-152406     Document Type: Article

References (112)

1. Watson SP, Auger JM, McCarty OJT, Pearce AC. 2005. GPVI and integrinαIIbβ3 signaling in platelets. J. Thromb. Haemost. 3:1752-62
2. Ruggeri ZM,Mendolicchio GL. 2007. Adhesion mechanisms in platelet function. Circ. Res. 100:1673-85
3. Flamm MH, Sinno T, Diamond SL. 2011. Simulation of aggregating particles in complex flows by the lattice kinetic Monte Carlo method. J. Chem. Phys. 134:034905
4. Laurenzi IJ, Diamond SL. 1999. Monte Carlo simulation of the heterotypic aggregation kinetics of platelets and neutrophils. Biophys. J. 77:1733-46
5. Hockin MF, Jones KC, Everse SJ, Mann KG. 2002. A model for the stoichiometric regulation of blood coagulation. J. Biol. Chem. 277:18322-33
6. Chatterjee MS, Denney WS, Jing H, Diamond SL. 2010. Systems biology of coagulation initiation: Kinetics of thrombin generation in resting and activated human blood. PLoS Comput. Biol. 6:e1000950
7. Fogelson AL, Hussain YH, Leiderman K. 2012. Blood clot formation under flow: The importance of factor XI depends strongly on platelet count. Biophys. J. 102:10-18
8. Fogelson AL, Kuharsky AL. 1998. Membrane binding-site density can modulate activation thresholds in enzyme systems. J. Theor. Biol. 193:1-18
9. Fogelson AL, Tania N. 2005. Coagulation under flow: The influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol. Haemost. Thromb. 34:91-108
10. Kuharsky AL, Fogelson AL. 2001. Surface-mediated control of blood coagulation: The role of binding site densities and platelet deposition. Biophys. J. 80:1050-74
11. Guy RD, Fogelson AL,Keener JP. 2007. Fibrin gel formation in a shear flow. Math.Med. Biol. 24:111-30
12. Diamond SL. 1999. Engineering design of optimal strategies for blood clot dissolution. Annu. Rev. Biomed. Eng. 1:427-62
13. Pivkin IV, Richardson PD, Karniadakis G. 2006. Blood flow velocity effects and role of activation delay time on growth and form of platelet thrombi. Proc. Natl. Acad. Sci. USA 103:17164-69
14. Flamm MH, Colace TV, Chatterjee MS, Jing H, Zhou S, et al. 2012. Multiscale prediction of patientspecific platelet function under flow. Blood 120:190-98
15. Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, et al. 2007. Shear-induced unfolding triggers adhesion of vonWillebrand factor fibers. Proc. Natl. Acad. Sci. USA 104:7899-903
16. Whitmore RL. 1968. Rheology of the Circulation. Oxford, UK: Pergamon
17. Lipowsky HH, Zweifach BW. 1977. Methods for the simultaneous measurement of pressure differentials and flow in single unbranched vessels of the microcirculation for rheological studies. Microvasc. Res. 14:345-61
18. Savage B, Saldivar E, Ruggeri ZM. 1996. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289-97
19. Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK, Lopez JA. 2001. Ristocetin-Dependent, but not botrocetin-Dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-Dependent interactions. Blood 97:162-68
20. Yago T, Lou J, Wu T, Yang J, Miner JJ, et al. 2008. Platelet glycoprotein Ibalpha forms catch bonds with humanWT vWF but not with type 2B von Willebrand disease vWF. J. Clin. Invest. 118:3195-207
21. Yago T,WuJ, WeyCD, Klopocki AG, ZhuC,McEver RP. 2004. Catch bonds govern adhesion through L-selectin at threshold shear. J. Cell Biol. 166:913-23
22. Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. 2005. Adhesion of human and mouse platelets to collagen under shear: A unifying model. FASEB J. 19:825-27
23. White-AdamsTC, BernyMA, Patel IA, Tucker EI,GailaniD, et al. 2010. Laminin promotes coagulation and thrombus formation in a factor XII-Dependent manner. J. Thromb. Haemost. 8:1295-301
24. Campos ITN, Guimaräes BG, Medrano FJ, Tanaka AS, Barbosa JARG. 2004. Crystallization, data collection and phasing of infestin 4, a factor XIIa inhibitor. Acta Crystallogr. D Biol. Crystallogr. 60:2051-53
25. Campos ITN, Tanaka-Azevedo AM, Tanaka AS. 2004. Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae). FEBS Lett. 577:512-16
26. Navaneetham D, Sinha D, Walsh PN. 2010. Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor. J. Biochem. 148:467-79
27. Tsai M, Kita A, Leach J, Rounsevell R, Huang JN, et al. 2012. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Invest. 122:408-18
28. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV. 1987. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J. Clin. Invest. 80:905-10
29. Zheng Y, Chen J, Craven M, Choi NW, Totorica S, et al. 2012. In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl. Acad. Sci. USA 109:9342-47
30. Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, et al. 1993. Real-Time analysis of sheardependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81:1263-76
31. Sakariassen KS, Bolhuis PA, Sixma JJ. 1979. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-VonWillebrand factor bound to the subendothelium. Nature 279:636-38
32. Aarts PA, Bolhuis PA, Sakariassen KS, Heethaar RM, Sixma JJ. 1983. Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood 62:214-17
33. Aarts PA, Heethaar RM, Sixma JJ. 1984. Red blood cell deformability influences platelets-vessel wall interaction in flowing blood. Blood 64:1228-33
34. SakariassenKS, Ottenhof-RoversM, Sixma JJ. 1984. Factor VIII-vonWillebrand factor requires calcium for facilitation of platelet adherence. Blood 63:996-1103
35. Sixma JJ, Sakariassen KS, Beeser-Visser NH, Ottenhof-Rovers M, Bolhuis PA. 1984. Adhesion of platelets to human artery subendothelium: Effect of factor VIII-vonWillebrand factor of various multimeric composition. Blood 63:128-39
36. WeissHJ, Tschopp TB, Baumgartner HR, Sussman II, JohnsonMM,Egan JJ. 1974. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am. J. Med. 57:920-25
37. Nurden AT, Caen JP. 1975. Specific roles for platelet surface glycoproteins in platelet function. Nature 255:720-22
38. Jenkins CS, Phillips DR, Clemetson KJ, Meyer D, Larrieu MJ, Luscher EF. 1976. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and vonWillebrand's disease. J. Clin. Invest. 57:112-24
39. NachmanRL, Jaffe EA, Weksler BB. 1977. Immunoinhibition of ristocetin-induced platelet aggregation. J. Clin. Invest. 59:143-48
40. Naim HY, Clemetson KJ, Luscher EF. 1982. Effects of galactose-binding lectins on human blood platelets: Identity of the peanut agglutinin receptor with the von Willebrand factor receptor. Thromb. Res. 26:431-41
41. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ. 1985. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318:470-72
42. Houdijk WP, Sakariassen KS, Nievelstein PF, Sixma JJ. 1985. Role of factor VIII-vonWillebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J. Clin. Invest. 75:531-40
43. Houdijk WP, Sixma JJ. 1985. Fibronectin in artery subendothelium is important for platelet adhesion. Blood 65:598-604
44. de Groot PG, Ottenhof-Rovers M, van Mourik JA, Sixma JJ. 1988. Evidence that the primary binding site of vonWillebrand factor that mediates platelet adhesion on subendothelium is not collagen. J. Clin. Invest. 82:65-73
45. Hindriks G, IjsseldijkMJW, Sonnenberg A, Sixma JJ, de Groot PG. 1992. Platelet adhesion to laminin: Role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood 79:928-35
46. Inoue O, Suzuki-Inoue K, McCarty OJT, Moroi M, Ruggeri ZM, et al. 2006. Laminin stimulates spreading of platelets through integrin α6β1- Dependent activation of GPVI. Blood 107:1405-12
47. Inoue O, Suzuki-Inoue K, Ozaki Y. 2008. Redundant mechanism of platelet adhesion to laminin and collagen under flow: Involvement of von Willebrand factor and glycoprotein Ib-IX-V. J. Biol. Chem. 283:16279-82
48. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. 1996. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 108:1903-10
49. Vandenberg P, Kern A, Ries A, Luckenbill-Edds L, Mann K, Kühn K. 1991. Characterization of a type IV collagen major cell binding site with affinity to the α1β1 and the α2β1 integrins. J. Cell Biol. 113:1475-83
50. Staatz WD, Rajpara SM, Wayner EA, Carter WG, Santoro SA. 1989. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-Dependent adhesion of platelets to collagen. J. Cell Biol. 108:1917-24
51. Asselin J, Gibbins JM, Achison M, Lee YH, Morton LF, et al. 1997. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C γ2 in platelets independent of the integrin α2β1. Blood 89:1235-42
52. Schaff M, Receveur N, Bourdon C, Wurtz V, Denis CV, et al. 2011. Novel function of tenascin-C, a matrix protein relevant to atherosclerosis, in platelet recruitment and activation under flow. Arterioscler. Thromb. Vasc. Biol. 31:117-24
53. Nemerson Y. 1968. The phospholipid requirement of tissue factor in blood coagulation. J. Clin. Invest. 47:72-80
54. Gemmell CH, Turitto VT,Nemerson Y. 1988. Flow as a regulator of the activation of factor X by tissue factor. Blood 72:1404-6
55. Shen F, Kastrup CJ, Liu Y, Ismagilov RF. 2008. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler. Thromb. Vasc. Biol. 28:2035-41
56. Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. 2008. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: Amplification of 100 fM circulating tissue factor requires flow. Blood 111:3507-13
57. Berny MA, Patel IA, White-Adams TC, Simonson P, Gruber A, et al. 2010. Rational design of an ex vivo model of thrombosis. Cell. Mol. Bioeng. 3:187-89
58. Hathcock JJ, Nemerson Y. 2004. Platelet deposition inhibits tissue factor activity: In vitro clots are impermeable to factor Xa. Blood 104:123-27
59. Gailani D, Broze GJ Jr. 1991. Factor XI activation in a revised model of blood coagulation. Science 253:909-12
60. Tucker EI, Marzec UM, White TC, Hurst S, Rugonyi S, et al. 2009. Prevention of vascular graft occlusion and thrombus-Associated thrombin generation by inhibition of factor XI. Blood 113:936-44
61. Cheng Q, Tucker EI, Pine MS, Sisler I,Matafonov A, et al. 2010. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 116:3981-89
62. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, et al. 1999. Blood-borne tissue factor: Another view of thrombosis. Proc. Natl. Acad. Sci. USA 96:2311-15
63. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. 2004. Hematopoietic cellderived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104:3190-97
64. Tormoen GW, Rugonyi S, Gruber A, McCarty OJT. 2011. The role of carrier number on the procoagulant activity of tissue factor in blood and plasma. Phys. Biol. 8:066005
65. Tormoen GW, Haley KM, Levine RL, McCarty OJT. 2012. Do circulating tumor cells play a role in coagulation and thrombosis? Front. Oncol. 2:115
66. Muller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, et al. 2009. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:1143-56
67. White-AdamsTC, BernyMA, Patel IA, Tucker EI,GailaniD, et al. 2010. Laminin promotes coagulation and thrombus formation in a factor XII-Dependent manner. J. Thromb. Haemost. 8:1295-301
68. Goel MS, Diamond SL. 2003. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-Adherent platelets. J. Biol. Chem. 278:9458-63
69. Goel MS,Diamond SL. 2001. Neutrophil enhancement of fibrin deposition under flow through plateletdependent and -independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 21:2093-98
70. Schmidtke DW, Diamond SL. 2000. Direct observation of membrane tethers formed during neutrophil attachment to platelets or P-selectin under physiological flow. J. Cell Biol. 149:719-29
71. Cooke BM, Usami S, Perry I, Nash GB. 1993. A simplified method for culture of endothelial cells and analysis of blood cells under conditions of flow. Microvasc. Res. 45:33-45
72. Kirton DM, Nash GB. 2000. Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. J. Lab. Clin.Med. 136:304-13
73. van Berkel SS, van der Lee B, van Delft FL, Wagenvoord R,HemkerHC, Rutjes FP. 2012. Fluorogenic peptide-based substrates for monitoring thrombin activity. ChemMedChem 7:606-17
74. Jackson GN, Ashpole KJ, Yentis SM. 2009. The TEG versus the ROTEM thromboelastography/ thromboelastometry systems. Anaesthesia 64:212-15
75. Viola F, Mauldin FW Jr, Lin-Schmidt X, Haverstick DM, Lawrence MB, Walker WF. 2010. A novel ultrasound-based method to evaluate hemostatic function of whole blood. Clin. Chim. Acta 411:106-13
76. Chatterjee MS, Purvis JE, Brass LF, Diamond SL. 2010. Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nat. Biotechnol. 28:727-32
77. Gosalia DN, Denney WS, Salisbury CM, Ellman JA, Diamond SL. 2006. Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray. Biotechnol. Bioeng. 94:1099-110
78. Gosalia DN, Salisbury CM, Ellman JA, Diamond SL. 2005. High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays. Mol. Cell Proteomics 4:626-36
79. Gosalia DN, Salisbury CM, Maly DJ, Ellman JA, Diamond SL. 2005. Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays. Proteomics 5:1292-98
80. SalisburyCM, Maly DJ, Ellman JA. 2002. Peptidemicroarrays for the determination of protease substrate specificity. J. Am. Chem. Soc. 124:14868-70
81. Maly DJ, Leonetti F, Backes BJ, Dauber DS, Harris JL, et al. 2002. Expedient solid-phase synthesis of fluorogenic protease substrates using the 7-Amino-4-carbamoylmethylcoumarin (ACC) fluorophore. J. Org. Chem. 67:910-15
82. Harris JL, Backes BJ, Leonetti F, Mahrus S, Ellman JA, Craik CS. 2000. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. USA 97:7754-59
83. Backes BJ, Harris JL, Leonetti F, Craik CS, Ellman JA. 2000. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nat. Biotechnol. 18:187-93
84. Gosalia D, Diamond SL. 2010. Nanodroplet chemical microarrays and label-free assays. Methods Mol. Biol. 669:69-78
85. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. 1988. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 71:1366-74
86. McCarty OJT, Abulencia JP,Mousa SA, Konstantopoulos K. 2004. Evaluation of platelet antagonists in in vitro flow models of thrombosis. Methods Mol. Med. 93:21-34
87. McDonald JC,Duffy DC, Anderson JR, Chiu DT,WuH, et al. 2000. Fabrication ofmicrofluidic systems in poly(dimethylsiloxane). Electrophoresis 21:27-40
88. Neeves KB, Maloney SF, Fong KP, Schmaier AA, Kahn ML, et al. 2008. Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear-resistance of platelet aggregates. J. Thromb. Haemost. 6:2193-301
89. Colace T, Falls E, Zheng XL, Diamond SL. 2011. Analysis of morphology of platelet aggregates formed on collagen under laminar blood flow. Ann. Biomed. Eng. 39:922-29
90. Maloney SF, Brass LF, Diamond SL. 2010. P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integr. Biol. 2:153-220
91. Gutierrez E, Petrich BG, Shattil SJ, Ginsberg MH, Groisman A, Kasierer-Friede A. 2008. Microfluidic devices for the studies of shear-Dependent platelet adhesion. Lab Chip 8:1486-95
92. Song H, Li HW, Munson MS, Van Ha TG, Ismagilov RF. 2006. On-chip titration of an anticoagulant argatroban and determination of the clotting time within whole blood or plasma using a plug-based microfluidic system. Anal. Chem. 78:4839-49
93. Pompano RR, Li HW, Ismagilov RF. 2008. Rate of mixing controls rate and outcome of autocatalytic processes: Theory and microfluidic experiments with chemical reactions and blood coagulation. Biophys. J. 95:1531-43
94. Neeves KB,Diamond SL. 2008.Amembrane-basedmicrofluidic device for controlling the flux of platelet agonists into flowing blood. Lab Chip 8:701-9
95. Neeves KB, Illing DA, Diamond SL. 2010. Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow. Biophys. J. 98:1344-52
96. Welsh JD, Colace TV,Muthard RW, Stalker TJ, Brass LF,Diamond SL. 2012. Platelet-Targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse. J. Thromb. Haemost. 10:2344-53
97. Muthard RW, Diamond SL. 2012. Blood clots are rapidly assembled hemodynamic sensors: Flow arrest triggers intraluminal thrombus contraction. Arterioscler. Thromb. Vasc. Biol. 32:2938-45
98. Colace TV,Muthard RW,Diamond SL. 2012. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: Role of thrombin with and without fibrin. Arteriocl. Thromb. Vasc. Biol. 32:1466-76
99. NesbittWS, Westein E,Tovar-Lopez JF, Tolouei E,Mitchell A, et al. 2009. A shear gradient-Dependent platelet aggregation mechanism drives thrombus formation. Nat. Med. 15:665-75
100. Tovar-Lopez FJ, Rosengarten G,Westein E, Khoshmanesh K, Jackson SP, et al. 2010. A microfluidics device to monitor platelet aggregation dynamics in response to strain rate micro-gradients in flowing blood. Lab Chip 10:291-302
101. Colace TV, Diamond SL. 2013. Direct observation of von Willebrand factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow. Arterioscler. Thromb. Vasc. Biol. 33:105-13
102. Kastrup CJ, Shen F, Runyon MK, Ismagilov RF. 2007. Characterization of the threshold response of initiation of blood clotting to stimulus patch size. Biophys. J. 93:2969-77
103. Shen F, Kastrup CJ, Liu Y, Ismagilov RF. 2008. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler. Thromb. Vasc. Biol. 28:2035-41
104. Colace TV, Jobson J, Diamond SL. 2011. Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidicmodel of vessel injury. Bioconjug. Chem. 22:2104-9
105. Corum LE, Eichinger CD, Hsiao TW, Hlady V. 2011. Using microcontact printing of fibrinogen to control surface-induced platelet adhesion and activation. Langmuir 27:8316-22
106. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. 1995. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: Collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem. J. 306:337-44
107. Hansen RR, Tipnis AA, White-Adams TC, Di Paola JA, Neeves KB. 2011. Characterization of collagen thin films for von Willebrand factor binding and platelet adhesion. Langmuir 27:13648-58
108. Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie G, Ginsberg MH. 1987. Arginyl-glycyl-Aspartic acid sequences and fibrinogen binding to platelets. Blood 70:110-15
109. Conant CG, Schwartz MC, Beecher JE, Rudoff RC, Iomesco-Zanetti C, Nevill JT. 2011. Well plate microfluidic system for investigation of dynamic platelet behavior under variable shear loads. Biotechnol. Bioeng. 108:2978-87
110. Hayward CPM,Harrison P,CattaneoM,Ortel TL, Rao AK. 2006. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J. Thromb. Haemost. 4:312-19
111. Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, et al. 2007. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12R- rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb. Res. 119:277-84
112. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. 2009. Thrombelestography and tromboelastometry in assessing coagulopathy in trauma. Scand. J. Trauma. Resusc. Emerg. Med. 17:45